No Data
No Data
Boston Scientific Announces Conference Call Discussing Third Quarter 2024 Results
BDX Upped to Buy by Citi, TNDM Put on Negative Catalyst Watch
Capital Markets' Top 30 Global Ideas for the Fourth Quarter
Boston Scientific Analyst Ratings
Evercore ISI Adjusts Price Target on Boston Scientific to $90 From $82
Conformal Medical Announces Launch of the GLACE Study With Next-Gen CLAAS AcuFORM Left Atrial Appendage Occlusion Device